Skip to main content

Advertisement

Log in

Enhancement of human mesenchymal stem cell differentiation by combination treatment with 5-azacytidine and trichostatin A

  • Original Research Paper
  • Published:
Biotechnology Letters Aims and scope Submit manuscript

Abstract

Objective

To enhance the differentiation of mesenchymal stem cells (MSCs) and their epigenetic status by modification using hypomethylating agents (HMAs) and histone deacetylase inhibitors (HDACs).

Results

Treatment with 5-azacytidine or 5-azacytidine plus trichostatin A (TSA) increased expression of Runx-2, BDNF and Sox-9 compared with the control or TSA groups. Maximal increases of 4.1-, 4.5-, and 8.3-fold in Runx-2, BDNF, and Sox-9 transcript levels, respectively, were observed in the 5-azacytidine plus TSA group. Similar to the expression pattern of key regulatory molecules, differentiation to each lineage was also enhanced considerably in the 5-azacytidine or in the 5-azacytidine plus TSA groups. Quantitative analyses at the protein level showed 8.9-, 26.8-, 27.9-, and 28.5-fold upregulation of osterix, MAP-2, nestin, and type II collagen), respectively.

Conclusion

HMAs and HDACs enhanced in vitro differentiation of MSCs, which was maximized when the two drugs were combined, with HMA having the dominant effect.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  • Cameron EE, Bachman KE, Myohanen S, Herman JG, Baylin SB (1999) Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nat Genet 21:103–107

    Article  PubMed  CAS  Google Scholar 

  • Caplan AI, Correa D (2011) The MSC: an injury drugstore. Cell Stem Cell 9:11–15

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Furumatsu T, Ozaki T (2010) Epigenetic regulation in chondrogenesis. Acta Med Okayama 64:155–161

    PubMed  CAS  Google Scholar 

  • Ghaemi SR, Harding FJ, Delalat B, Gronthos S, Voelcker NH (2013) Exploring the mesenchymal stem cell niche using high throughput screening. Biomaterials 34:7601–7615

    Article  PubMed  Google Scholar 

  • Griffin MD, Elliman SJ, Cahill E, English K, Ceredig R, Ritter T (2013) Concise review: adult mesenchymal stromal cell therapy for inflammatory diseases: how well are we joining the dots? Stem Cells 31:2033–2041

    Article  PubMed  CAS  Google Scholar 

  • Hsiao SH, Lee KD, Hsu CC, Tseng MJ, Jin VX, Sun WS et al (2010) DNA methylation of the rip10 promoter accelerates mesenchymal stem cell lineage determination. Biochem Biophys Res Commun 400:305–312

    Article  PubMed  CAS  Google Scholar 

  • Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR et al (2002) Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418:41–49

    Article  PubMed  CAS  Google Scholar 

  • Kang PL, Chen CH, Chen SY, Wu YJ, Lin CY, Lin FH et al (2013) Nano-sized collagen I molecules enhanced the differentiation of rat mesenchymal stem cells into cardiomyocytes. J Biomed Mater Res A 101:2808–2816

    Article  PubMed  Google Scholar 

  • Lee OK, Kuo TK, Chen WM, Lee KD, Hsieh SL, Chen TH (2004) Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood 103:1669–1675

    Article  PubMed  CAS  Google Scholar 

  • Lee S, Park JR, Seo MS, Roh KH, Park SB, Hwang JW et al (2009) Histone deacetylase inhibitors decrease proliferation potential and multilineage differentiation capability of human mesenchymal stem cells. Cell Prolifer 42:711–720

    Article  CAS  Google Scholar 

  • Majumder A, Dhara SK, Swetenburg R, Mithani M, Cao K, Medrzycki M et al (2013) Inhibition of DNA methyltransferases and histone deacetylases induces astrocytic differentiation of neural progenitors. Stem Cell Res 11:574–586

    Article  PubMed  CAS  Google Scholar 

  • Miller JL, Grant PA (2013) The role of DNA methylation and histone modifications in transcriptional regulation in humans. Subcell Biochem 61:289–317

    Article  PubMed  CAS  Google Scholar 

  • Nakatsuka R, Nozaki T, Uemura Y, Matsuoka Y, Sasaki Y, Shinohara M et al (2010) 5-aza-2′-deoxycytidine treatment induces skeletal myogenic differentiation of mouse dental pulp stem cells. Arch Oral Biol 55:350–357

    Article  PubMed  CAS  Google Scholar 

  • Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD et al (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284:143–147

    Article  PubMed  CAS  Google Scholar 

  • Rosca AM, Burlacu A (2011) Effect of 5-azacytidine: evidence for alteration of the multipotent ability of mesenchymal stem cells. Stem Cells Dev 20:1213–1221

    Article  PubMed  CAS  Google Scholar 

  • Xu S, De Veirman K, Evans H, Santini GC, Vande Broek I, Leleu X et al (2013) Effect of the HDAC inhibitor vorinostat on the osteogenic differentiation of mesenchymal stem cells in vitro and bone formation in vivo. Acta Pharmacol Sin 34:699–709

    Article  PubMed  CAS  PubMed Central  Google Scholar 

Download references

Acknowledgments

This study was supported by a grant from Sanofi Aventis, Korea. This research was partly supported by the National Research Foundation (NRF) funded by the Korean government (No. NRF-2012R1A1A2043735).

Supporting information

Supplementary Table 1—Primers used for real time-PCR analysis.

Supplementary Fig. 1—Flow cytometric analysis of the MSCs.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yoo-Jin Kim.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 13 kb)

Supplementary material 4 (TIFF 218 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kim, H.J., Kwon, YR., Bae, YJ. et al. Enhancement of human mesenchymal stem cell differentiation by combination treatment with 5-azacytidine and trichostatin A. Biotechnol Lett 38, 167–174 (2016). https://doi.org/10.1007/s10529-015-1949-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10529-015-1949-3

Keywords

Navigation